Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04436055 · ClinicalTrials.gov registry record
Intergenerational Effects of Paternal Periconceptional Cannabis and Other Drug Use (EPIC)
A clinical trial, sponsored by Duke University.
- Terminated
- Registry status
- 92
- Enrollment target
NCT04436055 is a clinical trial that was terminated before completion, run by Duke University. The registered enrollment target is 92 participants.
The verdict
NCT04436055 was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- 92 participants
- Enrollment target
Study Summary
The overall objective of this proposed project is to prospectively evaluate the epigenetic and developmental effects of paternal cannabis and other drug use in offspring.
Interventions
- OTHER No Intervention will be used
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2020-10-26 |
| Est. Completion | 2022-07-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04436055
The ClinicalTrials.gov registry entry for NCT04436055 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No Intervention will be used is the first listed.
NCT04436055 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04436055 about?
NCT04436055 is a clinical study titled "Intergenerational Effects of Paternal Periconceptional Cannabis and Other Drug Use (EPIC)". The overall objective of this proposed project is to prospectively evaluate the epigenetic and developmental effects of paternal cannabis and other drug use in offspring.
What is the current status of trial NCT04436055?
This trial is currently terminated. The enrollment target is 92 participants. The study started on 2020-10-26. Estimated completion is 2022-07-01.
What interventions are being tested in trial NCT04436055?
The interventions under investigation include: No Intervention will be used (OTHER).
Who is sponsoring clinical trial NCT04436055?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.